CRISPR Therapeutics to Participate in Upcoming Investor Conferences
May 26 2020 - 8:30AM
CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company
focused on creating transformative gene-based medicines for serious
diseases, today announced that members of its senior management
team are scheduled to participate virtually in the following
investor conferences in June:
Jefferies Global Healthcare Conference
Date: Tuesday, June 2, 2020Fireside chat: 1:30 p.m. ET
Goldman Sachs 41st Annual Global Healthcare
Conference Date: Tuesday, June 9, 2020 Fireside chat:
9:40 a.m. ET
A live webcast of these events will be available on the "Events
& Presentations" page in the Investors section of the Company's
website at https://crisprtx.com/events. A replay of the
webcast will be archived on the Company's website for 14 days
following the presentation.
About CRISPR TherapeuticsCRISPR
Therapeutics is a leading gene editing company focused on
developing transformative gene-based medicines for serious diseases
using its proprietary CRISPR/Cas9 platform. CRISPR/Cas9 is a
revolutionary gene editing technology that allows for precise,
directed changes to genomic DNA. CRISPR Therapeutics has
established a portfolio of therapeutic programs across a broad
range of disease areas including hemoglobinopathies, oncology,
regenerative medicine and rare diseases. To accelerate and expand
its efforts, CRISPR Therapeutics has established strategic
partnerships with leading companies including Bayer, Vertex
Pharmaceuticals and ViaCyte, Inc. CRISPR Therapeutics AG is
headquartered in Zug, Switzerland, with its wholly-owned U.S.
subsidiary, CRISPR Therapeutics, Inc., and R&D operations based
in Cambridge, Massachusetts, and business offices in San Francisco,
California and London, United Kingdom. For more information, please
visit www.crisprtx.com.
Investor Contact:Susan Kim+1
617-307-7503susan.kim@crisprtx.com
Media Contact:Rachel EidesWCG on behalf of
CRISPR+1 617-337-4167reides@wcgworld.com
CRISPR Therapeutics (NASDAQ:CRSP)
Historical Stock Chart
From Mar 2024 to Apr 2024
CRISPR Therapeutics (NASDAQ:CRSP)
Historical Stock Chart
From Apr 2023 to Apr 2024